A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
First approved CRISPR‑Cas9 gene‑editing therapy for sickle cell disease and β‑thalassemia
This milestone was not a bench research article per se, but it was published and highlighted in Nature as a historic biotechnology advance in the editorial and commentary sections of the journal: the approval of…
-
Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering
What It Reports What they did:The researchers developed a novel computational clustering algorithm called FLSHclust (fast locality-sensitive hashing clustering) that can rapidly search enormous protein sequence databases — billions of sequences — to identify CRISPR-associated…
-
A monomeric StayGold fluorescent protein
What the paper reports This study describes the development of mStayGold, a monomeric version of the highly bright and photostable fluorescent protein StayGold. StayGold itself is an exceptionally bright green fluorescent protein with very strong…
BioTech IP Review 